Filter
1778
Filtered Results: 1778
Text search:
molecular
Featured
Recommendations
205
New Publications
331
Language
Document type
No document type
780
Guidelines
394
Studies & Reports
317
Manuals
103
Strategic & Response Plan
76
Fact sheets
53
Training Material
19
Situation Updates
17
Resource Platforms
9
Infographics
7
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
70
Global
62
Brazil
61
Western and Central Europe
60
Africa
39
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Ethiopia
22
Tanzania
22
Peru
22
Argentina
20
West and Central Africa
20
Venezuela
20
Russia
18
East and Southern Africa
17
El Salvador
16
Paraguay
15
Uganda
14
Mozambique
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Senegal
11
Philippines
11
Rwanda
11
Nepal
10
Angola
10
Asia
10
Congo, Democratic Republic of
9
Zambia
9
Ukraine
9
Ecuador
9
Chile
9
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Haiti
4
Pakistan
4
Italy
4
Vietnam
4
France
4
Guinea
3
Burkina Faso
3
Lebanon
3
Cambodia
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Chad
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Morocco
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Switzerland
1
Cuba
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Palestine
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
615
Clinical Guidelines
223
Public Health
76
Pharmacy & Technologies
65
Key Resources
29
Women & Child Health
23
Capacity Building
6
Toolboxes
TB
389
COVID-19
279
AMR
113
NTDs
111
HIV
86
Rapid Response
78
Mental Health
78
Ebola
46
Planetary Health
46
Zika
33
Pharmacy
31
NCDs
27
Refugee
21
Polio
14
Caregiver
14
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
Update, 23 de junio de 2022
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Desde la notificación de los dos primeros casos confirmados de Vibrio cholerae O1 en el área del gran Puerto Príncipe el 2 de octubre de 2022, al 23 de octubre de 2022, el Ministerio de Salud de Haití (Ministère de la Santé Publique et de la Population, MSPP por sus siglas en francés), inform...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
Analysis of microfilaria prevalence data from 430 communities
January 2020 to December 2021
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
